Showing results (261-270 of 1,135) with videos related to
Sort By:
Pageof 114
Journal of Hepatocellular Carcinoma|July 12, 2022
Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular CarcinomaNorberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, et al.Journal of Hepatocellular Carcinoma|May 25, 2019
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectivesLi-Chun Lu, Chun-Jung Chang, Chih-Hung HsuJournal of Hepatocellular Carcinoma|July 26, 2022
Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and CirrhosisReham Hammad, Mona A Eldosoky, Alshaimaa M Mosaad, et al.Journal of Hepatocellular Carcinoma|August 16, 2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinomaKaterina Zakka, Renjian Jiang, Olatunji B Alese, et al.Journal of Hepatocellular Carcinoma|February 19, 2021
The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular CarcinomaSiming Li, Wentao Xu, Minjun Liao, et al.Journal of Hepatocellular Carcinoma|February 19, 2021
Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched AnalysisKangpyo Kim, Tae Hyung Kim, Tae Hyun Kim, et al.Journal of Hepatocellular Carcinoma|February 5, 2021
Recent Update on the Role of Circular RNAs in Hepatocellular CarcinomaAbdullah Ely, Kristie Bloom, Mohube Betty Maepa, et al.Journal of Hepatocellular Carcinoma|April 14, 2025
Rare Gingival Metastasis Occurring After Conversion Therapy Followed by Resection of Initially Unresectable Hepatocellular Carcinoma: A Case ReportJuncheng Zhan, Hongwei Huang, Tianao Zhan, et al.Journal of Hepatocellular Carcinoma|April 8, 2025
Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis BTong Wu, Jianguo Yan, Feixiang Xiong, et al.Journal of Hepatocellular Carcinoma|April 24, 2025
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology NetworkDavid Cosgrove, Ruoding Tan, Andrew J Osterland, et al.Pageof 114